GSK Withdrawn
CEP Certificates (EDQM COS List)
GSK Withdrawn
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 16
- Latest End Date 2026-04-07
- Data Source EDQM
- Last Updated 2001-11-21
Company Overview
Social Profiles
Company Snapshot
GSK Withdrawn
980 Great West Road, Brentford, Middlesex TW8 9GS England
United Kingdom
www.gsk.com:443/en-gb/ View on MapCEP Records Timeline (16 records)
Product
(6,7)-3-hydroxymethyl-7-(z-2-methoxyimino-2-(fur-2-yl)acetamido)ceph-3-em-4-carb, (640/2 sodium)
Substance
Glaxo Wellcome London GB
Certificate No.
R0-CEP 2000-275 - Rev 01
Substance No.
.
Issue Date
2001-11-21
End Date
2006-08-03
Country
United Kingdom
Identifiers
Certificate No.: R0-CEP 2000-275 - Rev 01
Substance No.: .
Product
Griseofulvin
Substance
Glaxo Wellcome London GB
Certificate No.
R0-CEP 2000-374 - Rev 01
Substance No.
182
Issue Date
2001-11-21
End Date
2006-07-11
Country
United Kingdom
Identifiers
Certificate No.: R0-CEP 2000-374 - Rev 01
Substance No.: 182
Product
Beclometasone dipropionate
Substance
Glaxo Wellcome Operations Montrose GB
Certificate No.
R1-CEP 1997-015 - Rev 02
Substance No.
654
Issue Date
2007-10-05
End Date
2025-04-07
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 1997-015 - Rev 02
Substance No.: 654
Product
Tetanus Toxoid, Purified, Concentrated
Substance
GlaxoSmithKline Biologicals Kft Gödöllö Gödöllö HU
Certificate No.
R0-CEP 2000-403 - Rev 02
Substance No.
.
Issue Date
2005-09-19
End Date
2006-11-24
Country
Hungary
Identifiers
Certificate No.: R0-CEP 2000-403 - Rev 02
Substance No.: .
Product
Labetalol Hydrochloride
Substance
GlaxoSmithKline Group of Companies Greenford GB
Certificate No.
R1-CEP 1998-119 - Rev 01
Substance No.
923
Issue Date
2008-07-16
End Date
2013-04-22
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 1998-119 - Rev 01
Substance No.: 923
Product
Mupirocin calcium
Substance
GlaxoSmithKline Research & Development Limited Brentford GB
Certificate No.
R1-CEP 2011-048 - Rev 00
Substance No.
1451
Issue Date
2017-06-02
End Date
2020-12-01
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 2011-048 - Rev 00
Substance No.: 1451
Product
Betamethasone valerate, Micronised
Substance
GlaxoSmithKline Research & Development Limited Brentford GB
Certificate No.
R1-CEP 2005-254 - Rev 02
Substance No.
811
Issue Date
2013-08-06
End Date
2015-06-04
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 2005-254 - Rev 02
Substance No.: 811
Product
Clobetasone butyrate, Micronised
Substance
GlaxoSmithKline Research & Development Limited Brentford GB
Certificate No.
R1-CEP 2006-186 - Rev 02
Substance No.
1090
Issue Date
2013-08-06
End Date
2015-06-04
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 2006-186 - Rev 02
Substance No.: 1090
Product
Cefuroxime axetil
Substance
GlaxoSmithKline Research & Development Limited Brentford GB
Certificate No.
R1-CEP 2002-050 - Rev 02
Substance No.
1300
Issue Date
2013-07-02
End Date
2019-10-24
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 2002-050 - Rev 02
Substance No.: 1300
Product
Zidovudine
Substance
GlaxoSmithKline Research & Development Limited Greenford GB
Certificate No.
R1-CEP 2001-321 - Rev 00
Substance No.
1059
Issue Date
2008-03-06
End Date
2014-08-01
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 2001-321 - Rev 00
Substance No.: 1059
Product
Mupirocin
Substance
GlaxoSmithKline Research & Development Limited London GB
Certificate No.
R1-CEP 2010-146 - Rev 01
Substance No.
1450
Issue Date
2017-10-02
End Date
2024-10-01
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 2010-146 - Rev 01
Substance No.: 1450
Product
Clobetasone butyrate, Micronised
Substance
GlaxoSmithKline Research & Development Limited London GB
Certificate No.
R1-CEP 2002-248 - Rev 05
Substance No.
1090
Issue Date
2015-04-13
End Date
2024-12-13
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 2002-248 - Rev 05
Substance No.: 1090
Product
Ceftazidime Pentahydrate
Substance
GlaxoSmithKline Research & Development Limited London GB
Certificate No.
R1-CEP 2004-306 - Rev 01
Substance No.
1405
Issue Date
2013-07-02
End Date
2026-04-07
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 2004-306 - Rev 01
Substance No.: 1405
Product
Cefuroxime sodium, Sterile
Substance
GlaxoSmithKline Research & Development Limited London GB
Certificate No.
R1-CEP 2005-208 - Rev 00
Substance No.
992
Issue Date
2013-07-02
End Date
2026-04-07
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 2005-208 - Rev 00
Substance No.: 992
Product
Potassium clavulanate, diluted, silica, colloidal hydrated in a ratio 1:1
Substance
Smithkline Beecham Pharmaceuticals Irvine GB
Certificate No.
R0-CEP 2006-068 - Rev 01
Substance No.
1653
Issue Date
2010-02-02
End Date
2011-03-28
Country
United Kingdom
Identifiers
Certificate No.: R0-CEP 2006-068 - Rev 01
Substance No.: 1653
Product
Potassium clavulanate, Sterile
Substance
Smithkline Beecham Pharmaceuticals Worthing GB
Certificate No.
R1-CEP 1999-113 - Rev 04
Substance No.
1140
Issue Date
2014-02-26
End Date
2026-02-26
Country
United Kingdom
Identifiers
Certificate No.: R1-CEP 1999-113 - Rev 04
Substance No.: 1140
Status Breakdown
16 total- Withdrawn by holder
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
United Kingdom
Identifiers
Certificate No.: R0-CEP 2000-275 - Rev 01
Substance No.: .
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.